Hackensack Meridian School of Medicine of New Jersey|Innovative Curriculum|State-of-the-Art Campus   

Hackensack Meridian School of Medicine Program Details

Our Admission Process

Designed to produce exceptional physicians who understand what drives health and disease.

Innovative Curriculum

Our innovative curriculum utilizes evidence-based teaching methods to promote effective and efficient student learning.

State-of-the-Art Campus

The 20-acre state-of-the-art campus features world-class facilities for health science research and discovery.

Human Dimension Course

Central to the curriculum, placing the individual, family, and community as the focus of medicine.

Milestone Events and Community Activities

Bonita Stanton 5K
Bonita Stanton, M.D., Memorial 5K

It is with great pleasure that we invite you to participate in our 2023 Inaugural Bonita Stanton, M.D., Memorial 5K.


SOM Welcomes Dr. Peter Hotez, Vaccine and Science Advocate, in Global Health Seminar

The Hackensack Meridian School of Medicine (HMSOM) welcomed one of the world’s most well known vaccine and science advocates, Dr. Peter Hotez, on Sept. 21.

Voices of HMSOM: Pema Brings Hard Work from the Pool to School

Though both his parents are physicians, Patrick Pema had no intention of becoming a doctor. All that changed with a single prognosis. When Pema was in high school, his mother developed preeclampsia during a pregnancy. The prognosis was very bleak – as Pema recalls it was a “very dark time” for the family, especially one Christmas in the hospital with mom under constant supervision.

Research Pilot Project Funding Program realizes excellent early returns for investigators

The Hackensack Meridian Health Research Institute, in collaboration with the Hackensack Meridian Hackensack University Medical Center Foundation and the Hackensack Meridian School of Medicine (HMSOM) provided seed funds for 11 research pilot project awards totaling greater than $200,000, in 2020 and 2021.

HMSOM Student Publishes Correspondence in The Lancet

A second-year Hackensack Meridian School of Medicine student has published a piece of correspondence in The Lancet which questions some recent research about injectables for treatment of schizophrenia. Maxwell Price co-authored the piece “The use of long-acting injectables in early-phase schizophrenia” in this month’s issue of the esteemed medical journal. His father, psychiatrist Richard L. Price of Weill Cornell Medical College, is the other author.

We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy. Accept All CookiesLearn More